Bo Zhang1, Xiang-Yu Wang1, Lu-Yu Yang1

  • 1Hepatobiliary Surgery, Department of General Surgery, Huashan Hospital & Cancer Metastasis Institute, Fudan University, Shanghai, China.

Updates in surgery
|April 2, 2025
PubMed
概括

TP53和KRAS突变预测了手术后淋巴结阴性肝内胆管癌 (ICC) 患者的早期和更积极的复发. 这些遗传标记突出了需要向治疗以改善结果的高风险患者.